본문 바로가기
KERD
논문KCI 등재

Circulating Endothelial Progenitor Cells in Cerebrovascular Disease

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

초록

Stroke is associated with high disability and mortality burdens worldwide, but there are few effective and widely available therapies. There is therefore a need to develop treatments that promote the repair and regeneration of ischemic brain tissue. In this regard, a population of adult stem cells-called endothelial progenitor cells (EPCs)-has been identified in peripheral blood that could provide novel approaches in regenerative medicine for curing patients with acute ischemic stroke. There is accumulating evidence that EPCs can repair damaged endothelia and attenuate the development and progression of atherosclerosis. Also, EPCs can be recruited in response to acute ischemic events and participate in reparative vasculogenesis. Most studies related to EPCs have involved patients with cardiovascular diseases, and there is emerging evidence that EPCs represent a risk marker and a potential therapeutic agent in cerebrovascular disease. Here we review the characteristics and biology of EPCs in cerebrovascular disease and discuss the challenges that must be addressed to clarify the role and therapeutic applicability of EPCs in cerebrovascular disease.

Abstract

Stroke is associated with high disability and mortality burdens worldwide, but there are few effective and widely available therapies. There is therefore a need to develop treatments that promote the repair and regeneration of ischemic brain tissue. In this regard, a population of adult stem cells-called endothelial progenitor cells (EPCs)-has been identified in peripheral blood that could provide novel approaches in regenerative medicine for curing patients with acute ischemic stroke. There is accumulating evidence that EPCs can repair damaged endothelia and attenuate the development and progression of atherosclerosis. Also, EPCs can be recruited in response to acute ischemic events and participate in reparative vasculogenesis. Most studies related to EPCs have involved patients with cardiovascular diseases, and there is emerging evidence that EPCs represent a risk marker and a potential therapeutic agent in cerebrovascular disease. Here we review the characteristics and biology of EPCs in cerebrovascular disease and discuss the challenges that must be addressed to clarify the role and therapeutic applicability of EPCs in cerebrovascular disease.

참고문헌 (60)

  1. Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study", Lancet, 349, pp.1498~1504 (1997)
  2. Hurtado O, "Neurorepair versus neuroprotection in stroke", Cerebrovasc Dis, 21, pp.54~63 (2006)
  3. Asahara T, "Isolation of putative progenitor endothelial cells for angiogenesis", Science, 275, pp.964~967 (1997)
  4. Hill JM, "Circulating endothelial progenitor cells, vascular function, and cardiovascular risk", N Engl J Med, 348, pp.593~600 (2003)
  5. Asahara T, "VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells", EMBO J, 18, pp.3964~3972 (1999)
  6. Murohara T, "Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization", J Clin Invest, 105, pp.1527~1536 (2000)
  7. Takahashi T, "Ischemia- and cytokine-induced mobilization of bone marrowderived endothelial progenitor cells for neovascularization", Nat Med, 5, pp.434~438 (1999)
  8. Vasa M, "Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease", Circ Res, 89, pp.E1~E7 (2001)
  9. Schatteman GC, "Bloodderived angioblasts accelerate blood-flow restoration in diabetic mice", J Clin Invest, 106, pp.571~578 (2000)
  10. Tepper OM, "Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures", Circulation, 106, pp.2781~2786 (2002)
  11. Fadini GP, "Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus", J Am Coll Cardiol, 45, pp.1449~1457 (2005)
  12. Schmidt-Lucke C, "Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair", Circulation, 111, pp.2981~2987 (2005)
  13. Werner N, "Circulating endothelial progenitor cells and cardiovascular outcomes", N Engl J Med, 313, pp.999~1007 (2005)
  14. Taguchi A, "Circulating CD34-positive cells provide an index of cerebrovascular function", Circulation, 109, pp.2972~2975 (2004)
  15. Ghani U, "Endothelial progenitor cells during cerebrovascular disease", Stroke, 36, pp.151~153 (2005)
  16. Lau KK, "Burden of carotid atherosclerosis in patients with stroke: relationships with circulating endothelial progenitor cells and hypertension", J Hum Hypertens, 21, pp.445~451 (2007)
  17. Sobrino T, "The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome", Stroke, 38, pp.2759~2764 (2007)
  18. Yip HK, "Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke", Stroke, 39, pp.69~74 (2008)
  19. Jung KH, "Identification of neuronal outgrowth cells from peripheral blood of stroke patients", Ann Neurol, 63, pp.312~322 (2008)
  20. Chu K, "Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke", Stroke, 39, pp.1441~1447 (2008)
  21. Petersen BE, "Bone marrow as a potential source of hepatic oval cells", Science, 284, pp.1168~1170 (1999)
  22. Orlic D, "Bone marrow cells regenerate infarcted myocardium", Nature, 410, pp.701~705 (2001)
  23. Brazelton TR, "From marrow to brain: expression of neuronal phenotypes in adult mice", Science, 290, pp.1775~1779 (2000)
  24. Keller G, "The hemangioblast. In: Stem Cell Biology" (2001), Cold Spring Harbor Laboratory Press
  25. Rafii S, "Circulating endothelial precursors: mystery, reality, and promise", J Clin Invest, 105, pp.17~19 (2000)
  26. Abbott JD, "Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury", Circulation, 110, pp.3300~3305 (2004)
  27. Asahara T, "Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization", Circ Res, 85, pp.221~228 (1999)
  28. Shintani S, "Mobilization of endothelial progenitor cells in patients with acute myocardial infarction", Circulation, 103, pp.2776~2779 (2001)
  29. Gill M, "Vascular trauma induces rapid but transient mobilization of VEGFR2 (+)AC133(+) endothelial precursor cells", Circ Res, 88, pp.167~174 (2001)
  30. Khan SS, "Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry", Cytometry B Clin Cytom, 64, pp.1~8 (2005)
  31. Yin AH, "Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells", Blood, 90, pp.5002~5012 (1997)
  32. Peichev M, "Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors", Blood, 95, pp.952~958 (2000)
  33. Ingram DA, "Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells", Blood, 106, pp.1525~1531 (2005)
  34. George J, "Comparative analysis of methods for assessment of circulating endothelial progenitor cells", Tissue Eng, 12, pp.331~335 (2006)
  35. Hur J, "Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis", Arterioscler Thromb Vasc Biol, 24, pp.288~293 (2004)
  36. Lin Y, "Origins of circulating endothelial cells and endothelial outgrowth from blood", J Clin Invest, 105, pp.71~77 (2000)
  37. Verma S, "Fundamentals of endothelial function for the clinical cardiologist", Circulation, 105, pp.546~549 (2002)
  38. Perticone F, "Prognostic significance of endothelial dysfunction in hypertensive patients", Circulation, 104, pp.191~196 (2001)
  39. Fadini GP, "Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged generalpopulation", Stroke, 37, pp.2277~2282 (2006)
  40. Taguchi A, "Therapeutic angiogenesis by autologous bone-marrow transplantation in a general hospital setting", Eur J Vasc Endovasc Surg, 25, pp.276~278 (2003)
  41. Tateishi-Yuyama E, "Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial", Lancet, 360, pp.427~435 (2002)
  42. Hamano K, "Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: clinical trial and preliminary results", Jpn Circ J, 65, pp.845~847 (2001)
  43. Beck H, "Participation of bone marrow-derived cells in long-term repair processes after experimental stroke", J Cereb Blood Flow Metab, 23, pp.709~717 (2003)
  44. Yang GY, "Attenuation of ischemia-induced mouse brain injury by SAG, a redox-inducible antioxidant protein", J Cereb Blood Flow Metab, 21, pp.722~733 (2001)
  45. Sairanen T, "Evolution of cerebral tumor necrosis factoralpha production during human ischemic stroke", Stroke, 32, pp.1750~1758 (2001)
  46. Graham SH, "Programmed cell death in cerebral ischemia", J Cereb Blood Flow Metab, 21, pp.99~109 (2001)
  47. Kusuyama T, "Effects of treatment for diabetes mellitus on circulating vascular progenitor cells", J Pharmacol Sci, 102, pp.96~102 (2006)
  48. Numaguchi Y, "The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction", Circulation, 114, pp.I114~I119 (2006)
  49. Döbert N, "Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDGPET and thallium SPECT", Eur J Nucl Med Mol Imaging, 31, pp.1146~1151 (2004)
  50. Lev EI, "Circulating endothelial progenitor cells and coronary collaterals in patients with non-ST segment elevation myocardial infarction", J Vasc Res, 42, pp.408~414 (2005)
  51. Goolsby J, "Hematopoietic progenitors express neural genes", Proc Natl Acad Sci U S A, 통권 : 100, pp.14926~14931 (2003)
  52. Sanchez-Ramos JR, "Expression of neural markers in human umbilical cord blood", Exp Neurol, 171, pp.109~115 (2001)
  53. Mezey E, "Transplanted bone marrow generates new neurons in human brains", Proc Natl Acad Sci U S A, 통권 : 100, pp.1364~1369 (2003)
  54. Carmeliet P, "Mechanisms of angiogenesis and arteriogenesis", Nat Med, 6, pp.389~395 (2000)
  55. Yoon YS, "Myocardial regeneration with bonemarrow- derived stem cells", Biol Cell, 97, pp.253~263 (2005)
  56. Taguchi A, "Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model", J Clin Invest, 114, pp.330~338 (2004)
  57. Chen J, "Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats", Stroke, 32, pp.2682~2688 (2001)
  58. Zhang ZG, "Bone marrow-derived endothelial progenitor cells participate in cerebral neovascularization after focal cerebral ischemia in the adult mouse", Circ Res, 90, pp.284~288 (2002)
  59. Shyu WC, "Intracerebral peripheral blood stem cell (CD34+) implantation induces neuroplasticity by enhancing beta1 integrin-mediated angiogenesis in chronic stroke rats", J Neurosci, 26, pp.3444~3453 (2006)
  60. Ukai R, "Mesenchymal stem cells derived from peripheral blood protects against ischemia", J Neurotrauma, 24, pp.508~520 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (5건)